Effect of CYP3A5, CYP3A4 and ABCB1 polymorphisms on tacrolimus exposure in renal transplantation patients

被引:0
|
作者
Ajmi, M. [1 ,2 ]
Sahtout, W. [3 ]
Omezzine, A. [1 ,4 ]
Amor, D. [1 ]
Abderahmene, A. [1 ,4 ]
Azzabi, A. [3 ]
Ben-Rejeb, N. [1 ,4 ]
Achour, A. [3 ]
Bouslama, A. [1 ,4 ]
机构
[1] Sahloul Univ Hosp, Dept Biochem, LR12SP11, Sousse, Tunisia
[2] Higher Inst Biotechnol Monastir, Sousse, Tunisia
[3] Sahloul Univ Hosp, Dept Nephrol, Sousse, Tunisia
[4] Univ Monastir, Fac Pharm, Sousse, Tunisia
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
PS2 - 050
引用
收藏
页码:89 / 89
页数:1
相关论文
共 50 条
  • [31] Polymorphisms in CYP3A5, CYP3A4 and ABCB1 Are Not Associated with Cyclosporine-Pharmacokinetics nor with the Risk of Acute Rejection after Renal Transplantation.
    Bouamar, Rachida
    Hesselink, Dennis A.
    Weimar, Willem
    van Schaik, Ron H. N.
    van Gelder, Teun
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 418 - 418
  • [32] Association between CYP3A4, CYP3A5, and ABCB1 Genotype, Tacrolimus Concentrations, and Outcomes Among Allogeneic Hematopoietic Stem Cell Transplantation Patients
    Ho, Teresa
    Perkins, Janelle
    Gonzalez, Rebecca
    Hicks, J. Kevin
    Nishihori, Taiga
    Bejanyan, Nelli
    Pidala, Joseph
    Elmariah, Hany
    BLOOD, 2021, 138
  • [33] Effect of cyp3a5 and abcb1 polymorphisms on dose requirement and trough concentration of tacrolimus in renal transplant recipients
    Yildirim, E.
    Sahin, G.
    Kaltus, Z.
    Colak, E.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 : S84 - S85
  • [34] Impact of CYP3A4/5 and ABCB1 polymorphisms on tacrolimus exposure and response in pediatric primary nephrotic syndrome
    Huang, Lingfei
    Wang, Junyan
    Yang, Jufei
    Zhang, Huifen
    Ni, Yinghua
    Zhu, Zhengyi
    Wang, Huijuan
    Gao, Peng
    Wu, Yuanyuan
    Mao, Jianhua
    Fang, Luo
    PHARMACOGENOMICS, 2019, 20 (15) : 1071 - 1083
  • [35] Effect of CYP3A4, CYP3A5, ABCB1 Gene Polymorphisms on Rivaroxaban Pharmacokinetics in Patients Undergoing Total Hip and Knee Replacement Surgery
    Dmitry Sychev
    Radik Minnigulov
    Pavel Bochkov
    Kristina Ryzhikova
    Irina Yudina
    Aleksey Lychagin
    Tatyana Morozova
    High Blood Pressure & Cardiovascular Prevention, 2019, 26 : 413 - 420
  • [36] Effect of CYP3A4, CYP3A5, ABCB1 Gene Polymorphisms on Rivaroxaban Pharmacokinetics in Patients Undergoing Total Hip and Knee Replacement Surgery
    Sychev, Dmitry
    Minnigulov, Radik
    Bochkov, Pavel
    Ryzhikova, Kristina
    Yudina, Irina
    Lychagin, Aleksey
    Morozova, Tatyana
    HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2019, 26 (05) : 413 - 420
  • [37] CYP3A7, CYP3A5, CYP3A4, and ABCB1 Genetic Polymorphisms, Cyclosporine Concentration, and Dose Requirement in Transplant Recipients
    Crettol, Severine
    Venetz, Jean-Pierre
    Fontana, Massimiliano
    Aubert, John-David
    Pascual, Manuel
    Eap, Chin B.
    THERAPEUTIC DRUG MONITORING, 2008, 30 (06) : 689 - 699
  • [38] Effects of CYP3A5, ABCB1 and POR*28 polymorphisms on pharmacokinetics of tacrolimus in the early period after renal transplantation
    Ling, Jing
    Dong, Lu-Lu
    Yang, Xu-Ping
    Qian, Qing
    Jiang, Yan
    Zou, Su-Lan
    Hu, Nan
    XENOBIOTICA, 2020, 50 (12) : 1501 - 1509
  • [39] Diltiazem on tacrolimus exposure and dose sparing in Chinese pediatric primary nephrotic syndrome: impact of CYP3A4, CYP3A5, ABCB1, and SLCO1B3 polymorphisms
    Wang, Junyan
    Huang, Lingfei
    Gao, Peng
    Hu, Yan
    Ni, Yinghua
    Zhu, Zhengyi
    Zhang, Liwen
    Yang, Jufei
    Zhang, Huifen
    Fang, Luo
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (01) : 71 - 77
  • [40] Impact of CYP3A4, CYP3A5 and ABCB1 genotype and intestinal expression on the pharmacokinetics of budesonide
    Ufer, M.
    Dilger, K.
    Leschhorn, L.
    Daufresne, L. M.
    Mosyagin, I.
    Rosenstiel, P.
    Haesler, R.
    Nikolaus, S.
    Schreiber, S.
    Cascorbi, I.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2007, 101 (05) : 379 - 379